Global Mice Model Market Size, Share, Growth, Trends, Company Analysis and Forecast 2019-2026

The global mice model market size is expected to reach USD 3.79 billion by 2026, at a CAGR of 9.8% from 2019 to 2026.

This market is majorly driven by “continuing modification in mice model for cancers, immune diseases, and rare diseases; increasing devouring of personalized medicine propelling demand for humanized mice model; rising grants and investments for biological research; rising pharmaceutical R&D activities; and increasing focus of International Mouse Phenotyping Consortium (IMPC) and International Knockout Mouse Consortium (IKMC) on the development of embryonic stem cells as well as knockout and mutant mice.”

CRISPR-Cas9 gene editing technology with its ease to perform, versatility, and high efficiency has significantly improved the production of desired modified alleles. This technology has enabled rapid production of knockout, conditional alleles or mice carrying single point mutations, which mimic those in human patients, in only several weeks. Thus, this technology provides significant potential in near future.

The world mice model market is envisaged to be primarily advantaged by the growing investments in biomedical research which plays a vital role in pharmaceutical and healthcare sectors. Investment in biomedical research is considered to be a crucial determinant for gauging the level of research and development achieved by a nation. Mice models could attract a decent demand in such investments, which could eventually increase in the near future because of their diversified applications.

Recently, a mice model with fragile X syndrome was used to test the effect of metformin, a type 2 diabetes drug. The results revealed a reversal of brain and behavioral abnormalities in the mice model. According to the report offered herewith, the world mice model market could find extensive opportunities birthing from different type, specialty, and services segments.

The authors of the report have provided a vast study of the world mice model market in terms of several aspects such as business opportunities, restraining factors, key drivers, and vendor landscape. Readers are expected to gain a significant understanding of the market and plan for a better position therein.

Trends and Opportunities

The employment of mice models by the ALS Association for deep research on the disease amyotrophic lateral sclerosis (ALS) is regarded as a fine instance of the rising demand in the market. This is evident of the latest developments in various services and types of mice model that are anticipated to improve existing research procedures. The penetration of mice models in several medical research domains could be another factor strengthening the demand in the market.

Irrigation assay system, computer-generated simulations, and other alternative solutions incorporating a streamlined procedure and faster conclusion development process are foretold to impede the growth of the world mice model market. This could be owing to the efforts to reduce or restrict the requirement of animal models. However, studies of advanced diseases incorporating the application of new mice models are prognosticated to add to the growth of the market. Lung disease repair and other cutting-edge researches also cover the use of innovative mice models.

Geographical Analysis

Expert analysts foresee the international mice model market to mainly operate in key geographies such as Asia Pacific, Europe, North America, the Middle East and Africa, Latin America, and Rest of the World. In respect of revenue, North America could take a leading position in the market with a significant share secured under its belt. Narrowly followed by Asia Pacific, Europe is anticipated to be another region cementing a strong position in the market. Both these markets could be riding on their sophisticated biosciences research and well-established pharmaceutical sectors.

Nevertheless, the staggering shares in North America and Europe are predicted to lose their grip on the international mice model market in future on account a telling demand in Asia Pacific. Nearly half of the business for transgenic and knockout mice models could be taken up by Asia Pacific in Singapore, Malaysia, India, and China.

Companies Mentioned

Some of the important players studied in this research publication could be Harlan Laboratories, Inc., GenOway S.A., Deltagen, Inc., Crescendo Biologics Limited, and Charles River Laboratories. A quality analysis of the key companies operating in the worldwide mice model market is expected to help participants to stay watchful and make informed decisions in their business operations.

Report Scope:

This research report categorizes the global mice model market into the following segments:

By Model Type

  • Outbred Mice
  • Inbred Mice
  • Knockout/Genetically Modified Mice
  • Hybrid/Congenic Mice
  • Conditioned/Surgically Modified Mice
  • Immunodeficient Mice

By Service

  • Breeding
  • Cryopreservation
  • Quarantine
  • Rederivation
  • Model-in-licensing
  • Genetic Testing
  • Other Services

By Therapeutic Area

  • Other disease studies

By Technology

  • Microinjection
  • Embryonic Stem Cell Injection
  • Nuclear Transfer
  • Other Technologies

By Care Product

  • Cages
  • Feed
  • Bedding
  • Other Care Products

By Geography

  •  North America
  • Europe
  • Asia-Pacific
  • Rest of the World

Report Detail

Proceed To Buy

USD 3500
USD 6000